Basic information
- CAS
100678-32-8- Standard SMILES
O=C(O)CCC(=O)O.c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1- InChIKey
XFUIOIWYMHEPIE-UHFFFAOYSA-N- Molecular formula
- C22H24N2O4
- Average molar mass
- 380.4 g/mol
- Monoisotopic mass
- 380.17360725
Overview
Cibenzoline succinate is a diarylmethane.
Names & identifiers
- Preferred name
- Cibenzoline Succinate
- IUPAC
- butanedioic acid;2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
- English name
- Cibenzoline succinate
- Molecular formula
- C18H18N2
- Molecular weight
- 262.34892
Names & synonyms
cibenzoline succinate100678-32-8CIFENLINE SUCCINATECibenolDTXSID0047820Ro 22-7796/00138G16RWJ37DTXCID8027797Ro-227796001RO-22-7796/001RefChem:1261162-((1RS)-2,2-Diphenylcyclopropan-1-yl)-4,5-dihydro-1H-imidazole monosuccinate
Show more names
1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, butanedioate (9CI)Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
634-471-4CipralanCibenzolinesuccinate2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate85589-37-3Cifenline succinate [USAN]ExacorCibenzoline succinate [JAN]
Database identifiers
- CAS
100678-32-8、85589-37-3- PubChem CID
- 57952
- DTXSID
DTXSID0047820- ChEMBL
CHEMBL2106074、CHEMBL3189111- ChEBI
CHEBI:31396- UNII
Properties
Computed structural properties
- Topological polar surface area
- 99 Ų
- Hydrogen bond donors
- 3
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 6
- Heavy atoms
- 28
- Formal charge
- 0
- Complexity
- 449
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.
Hazard information
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Suppliers9 total
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
TargetMol 中国（陶术生物）400-821-0310 15002144251 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
安耐吉化学&3A（安徽泽升科技股份有限公司）400-0056266 · [email protected]
艾吉析科技（上海）有限公司17717235263 17717235263 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 19370895928 · [email protected]
Jilin Chinese Academy of Sciences-yanshen Technology18143011203 · [email protected]
重庆卡兰医药有限公司[email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…